140 related articles for article (PubMed ID: 23665160)
1. Predicting parkinsonism: new opportunities from Gaucher disease.
Lopez G; Sidransky E
Mol Genet Metab; 2013 Jul; 109(3):235-6. PubMed ID: 23665160
[No Abstract] [Full Text] [Related]
2. Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.
McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AH
Mol Genet Metab; 2013 Jun; 109(2):221-3. PubMed ID: 23639447
[TBL] [Abstract][Full Text] [Related]
3. Novel G377S (c.1246G>T) mutation associated with Gaucher disease type 1.
Zhou Y; Kraemer RR; Peker D; Wakefield DN; de Idiaquez Bakula DA
Am J Hematol; 2013 Oct; 88(10):922-3. PubMed ID: 23828321
[No Abstract] [Full Text] [Related]
4. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
Tayebi N; Walker J; Stubblefield B; Orvisky E; LaMarca ME; Wong K; Rosenbaum H; Schiffmann R; Bembi B; Sidransky E
Mol Genet Metab; 2003 Jun; 79(2):104-9. PubMed ID: 12809640
[TBL] [Abstract][Full Text] [Related]
5. Parkinsonism among Gaucher disease carriers.
Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.
Sidransky E; Sherer DM; Ginns EI
Pediatr Res; 1992 Oct; 32(4):494-8. PubMed ID: 1437405
[TBL] [Abstract][Full Text] [Related]
7. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?
Stone DL; van Diggelen OP; de Klerk JB; Gaillard JL; Niermeijer MF; Willemsen R; Tayebi N; Sidransky E
Eur J Hum Genet; 1999; 7(4):505-9. PubMed ID: 10352942
[TBL] [Abstract][Full Text] [Related]
8. Type 2 gaucher disease: an expanding phenotype.
Tayebi N; Stone DL; Sidransky E
Mol Genet Metab; 1999 Oct; 68(2):209-19. PubMed ID: 10527671
[No Abstract] [Full Text] [Related]
9. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.
Weill Y; Zimran A; Zadok D; Wasser LM; Revel-Vilk S; Hanhart J; Dinur T; Arkadir D; Becker-Cohen M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987733
[TBL] [Abstract][Full Text] [Related]
10. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature.
Kraoua I; Stirnemann J; Ribeiro MJ; Rouaud T; Verin M; Annic A; Rose C; Defebvre L; Réménieras L; Schüpbach M; Belmatoug N; Vidailhet M; Sedel F
Mov Disord; 2009 Jul; 24(10):1524-30. PubMed ID: 19513999
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel three-nucleotide insertion mutation (c.841-842insTGA) in the acid beta-glucosidase gene of a Taiwan Chinese patient with type II Gaucher disease.
Wu JY; Wu MC; Lee CC; Tsai FJ
Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241851
[No Abstract] [Full Text] [Related]
12. Gaucher disease diagnosed in a 30-year-old black man.
Nithya P; Constantine A; Roger V; Albert B
Clin Genet; 2008 Oct; 74(4):399-400. PubMed ID: 18637939
[No Abstract] [Full Text] [Related]
13. [Picture in clinical hematology no. 67].
Rinsho Ketsueki; 2013 Nov; 54(11):2023. PubMed ID: 24305533
[No Abstract] [Full Text] [Related]
14. White vitreous opacities in five patients with Gaucher disease type 3.
Seehra GK; Eghbali A; Sidransky E; FitzGibbon E
Am J Med Genet A; 2020 Apr; 182(4):808-812. PubMed ID: 31898869
[TBL] [Abstract][Full Text] [Related]
15. Gaucher Disease Involving Virchow's Lymph Node: a Case Report.
Zinovkin DA; Pranjol MZI; Kravchenko D; Kravchenko O; Kudryashov V
Folia Med (Plovdiv); 2018 Dec; 60(4):647-650. PubMed ID: 31188768
[TBL] [Abstract][Full Text] [Related]
16. Genotype D399N/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370S/R463C.
Tayebi N; Herman J; Ginns EI; Sidransky E
Biochem Mol Med; 1996 Apr; 57(2):149-51. PubMed ID: 8733893
[TBL] [Abstract][Full Text] [Related]
17. New perspectives in type 2 Gaucher disease.
Sidransky E
Adv Pediatr; 1997; 44():73-107. PubMed ID: 9265968
[No Abstract] [Full Text] [Related]
18. Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S).
Bodamer OA; Church HJ; Cooper A; Wraith JE; Scott CR; Scaglia F
Am J Med Genet; 2002 May; 109(4):328-31. PubMed ID: 11992489
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibility.
Ruchlemer R; Maayan H; Elstein D; Broide E; Reinus C; Zimran A
Blood Cells Mol Dis; 2014 Dec; 53(4):219-20. PubMed ID: 25053276
[No Abstract] [Full Text] [Related]
20. Gaucher disease and parkinsonism.
Sidransky E
Mol Genet Metab; 2005 Apr; 84(4):302-4. PubMed ID: 15781189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
